Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and DeathGustavo E. Velásquez, Salmaan Keshavjee, Askar Yedilbayev et al.|Clinical Infectious Diseases|2014Cited by 51
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant TuberculosisKwonjune J. Seung, Carole D. Mitnick, Palwasha Khan et al.|Clinical Infectious Diseases|2019Cited by 20